Efficacy and Safety of Saccharomyces boulardii for Acute Diarrhea

@article{Feizizadeh2014EfficacyAS,
  title={Efficacy and Safety of Saccharomyces boulardii for Acute Diarrhea},
  author={S. Feizizadeh and A. Salehi-Abargouei and V. Akbari},
  journal={Pediatrics},
  year={2014},
  volume={134},
  pages={e176 - e191}
}
BACKGROUND AND OBJECTIVE: The efficacy of Saccharomyces boulardii for treatment of childhood diarrhea remains unclear. Our objective was to systematically review data on the effect of S. boulardii on acute childhood diarrhea. METHODS: Our data sources included Medline, Embase, CINAHL, Scopus, and The Cochrane Library up to September 2013 without language restrictions. Randomized controlled trials and non-randomized trials that evaluated effectiveness of S. boulardii for treatment of acute… Expand
Efficacy and Safety of Saccharomyces boulardii in Acute Rotavirus Diarrhea: Double Blind Randomized Controlled Trial from a Developing Country.
TLDR
The present trial showed that Saccharomyces boulardii is effective and safe in acute rotavirus diarrhea. Expand
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Saccharomyces boulardii in Infants and Children With Acute Diarrhea
TLDR
Assessment of the efficacy and safety of Saccharomyces cerevisiae variant boulardii CNCM I-3799 in children with acute diarrhea showed it was effective in reducing the duration and severity of diarrhea in infants and children. Expand
Comparative effectiveness and safety of interventions for acute diarrhea and gastroenteritis in children: A systematic review and network meta-analysis
TLDR
Most interventions analyzed showed evidence of superiority to placebo in reducing the diarrhea, and no further role is suggested for studies comparing interventions against no treatment or placebo, or studies testing loperamide, MN, kaolin-pectin, vitamin A, prebiotics and diluted milk. Expand
Common Organisms and Probiotics: Saccharomyces boulardii
TLDR
Saccharomyces boulardii was well tolerated by study participants, regardless of age, or disease condition, and the most robust evidence-based efficacy is for the treatment of acute pediatric diarrhea, for the prevention of antibiotic-associated diarrhea, and for the treating of Helicobacter pylori infections. Expand
Systematic Review with Meta-Analysis: Lactobacillus reuteri DSM 17938 for Treating Acute Gastroenteritis in Children. An Update
TLDR
The effectiveness of Lactobacillus reuteri DSM 17938 for the management of acute gastroenteritis (AGE) has been recently questioned and the small effect sizes of limited clinical relevance and methodological limitations of the included trials should be noted when interpreting these findings. Expand
Saccharomyces boulardii and bismuth subsalicylate as low-cost interventions to reduce the duration and severity of cholera
TLDR
A randomised single-blinded clinical trial to determine if the probiotic Saccharomyces cerevisiae var. Expand
Specific Probiotics for the Treatment of Pediatric Acute Gastroenteritis in India: A Systematic Review and Meta-Analysis
Supplemental Digital Content is available in the text. Pediatric acute gastroenteritis (PAGE) is a significant cause of morbidity, mortality and healthcare costs in many countries, but differences inExpand
Role of Saccharomyces Boulardii and Bacillus Clausii in Children with Acute Diarrhea – A Randomized Control Trial
TLDR
Probiotics as an add on therapy would aid in decreasing the duration of diarrhea in acutepatients with acute diarrhea. Expand
Xyloglucan for the treatment of acute diarrhea: results of a randomized, controlled, open-label, parallel group, multicentre, national clinical trial
TLDR
Xyloglucan was more effective than diosmectite and S. bouliardii in reducing abdominal pain, with a constant improvement observed throughout the study, and the clinical evolution of flatulence followed similar patterns in the three groups, with continuous improvement of the symptom. Expand
Protective Effect of Enterococcus faecium SF68 and Saccharomyces boulardii in Acute Severe Diarrhea in Infants: Randomized Controlled Trial
TLDR
Enterococcus faecium SF68 and Saccharomyces boulardii helped to reduce the stool frequency, duration of diarrhea, length of hospital stay and also improved the stool consistency in acute severe diarrhea in infants. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 89 REFERENCES
Efficacy and Safety of Saccharomyces boulardii in Acute Childhood Diarrhea: A Double Blind Randomised Controlled Trial
TLDR
There is initial evidence available that Saccharomyces boullardi may have a therapeutic role in the management of acute childhood diarrhea. Expand
Efficacy and safety of Saccharomyces boulardii in amebiasis-associated diarrhea in children.
TLDR
Addition of S. boulardii to antibiotic treatment of amebiasis-associated acute diarrhea in children does not seem to be more effective than metronidazole treatment alone, and the tolerance and side effects of the treatment regimens are similar. Expand
Treatment of Acute Diarrhea With Saccharomyces boulardii in Infants
TLDR
The present study shows a reduction in diarrhea duration when S boulardii was given to children within 72 hours after the onset of acute diarrhea. Expand
Clinical efficacy comparison of Saccharomyces boulardii and yogurt fluid in acute non-bloody diarrhea in children: a randomized, controlled, open label study.
TLDR
In conclusion, the effect of daily freshly prepared YF was comparable to S. boulardii in the treatment of acute non-bloody diarrhea in children and the duration of diarrhea was shorter, expressed as a significantly higher number of patients with normal stools on day 3. Expand
Effect of Saccharomyces boulardii in the treatment of acute watery diarrhea in Myanmar children: a randomized controlled study.
TLDR
Saccharomyces boulardii shortens the duration of diarrhea and normalizes stool consistency and frequency and results in a social and economic benefits. Expand
Clinical efficacy of Saccharomyces boulardii or metronidazole in symptomatic children with Blastocystis hominis infection
TLDR
Metronidazole or S. boulardii has potential beneficial effects in B. hominis infection (symptoms, presence of parasites). Expand
Saccharomyces boulardii for treating acute gastroenteritis in children: updated meta‐analysis of randomized controlled trials
TLDR
This update of the meta-analysis of data from RCTs confirms that in otherwise healthy infants and children, the use of S. boulardii is associated with clinical benefits in the treatment of AGE, specifically a reduction in the duration of diarrhoea by approximately 1 day. Expand
Comparison of efficacy of Saccharomyces boulardii strain in the treatment of acute diarrhea in children: A prospective, single-blind, randomized controlled clinical trial
TLDR
In this study, prescriptions of 32% of the patients have violated the standard treatment protocol suggested by the IAP, which is even more alarming because current teaching of medical students completely lacks thrust on proper case management of diarrhea. Expand
Effects of Saccharomyces boulardii in children with acute diarrhoea
TLDR
The medians of the average stool frequency after the second day of the treatment were significantly lower in the S. boulardii group than in the placebo group, and the duration of diarrhoea was significantly reduced in the Hsieh group compared with theplacebo group. Expand
Saccharomyces boulardii for Clostridium difficile-associated enteropathies in infants.
TLDR
An open trial to examine the effects of the living yeast, given as primary therapy, in a selected group of infants and children with persistent intestinal symptoms related to toxinogenic C. difficile overgrowth. Expand
...
1
2
3
4
5
...